Shares of Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) rose 4.3% during trading on Tuesday . The company traded as high as $2.45 and last traded at $2.40. Approximately 1,636 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 842,200 shares. The stock had previously closed at $2.30.
Ampliphi Biosciences Stock Down 5.0 %
Ampliphi Biosciences Company Profile
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Articles
- Five stocks we like better than Ampliphi Biosciences
- How to Calculate Options Profits
- 3 Leveraged ETFs to Multiply Returns
- There Are Different Types of Stock To Invest In
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- What is the S&P/TSX Index?
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
